2-Jan-2026
No headlines found.
Pennant Group to Participate in the 2025 Stephens Annual Investment Conference
Globe Newswire (Thu, 6-Nov 9:22 AM ET)
The Pennant Group Announces Expansion of Credit Facility
Globe Newswire (Wed, 5-Nov 4:10 PM ET)
Pennant Reports Third Quarter 2025 Results
Globe Newswire (Wed, 5-Nov 4:05 PM ET)
Pennant Acquires Senior Living Communities in Idaho and Wisconsin
Globe Newswire (Tue, 4-Nov 6:48 PM ET)
Pennant Announces Third Quarter 2025 Earnings Release and Call
Globe Newswire (Fri, 24-Oct 5:55 PM ET)
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
Pennant Group trades on the NASDAQ stock market under the symbol PNTG.
As of January 2, 2026, PNTG stock price declined to $27.83 with 158,238 million shares trading.
PNTG has a beta of 0.59, meaning it tends to be less sensitive to market movements. PNTG has a correlation of 0.07 to the broad based SPY ETF.
PNTG has a market cap of $961.86 million. This is considered a Small Cap stock.
Last quarter Pennant Group reported $229 million in Revenue and $.30 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.04.
In the last 3 years, PNTG traded as high as $37.13 and as low as $10.00.
The top ETF exchange traded funds that PNTG belongs to (by Net Assets): VTI, IWM, VXF, IWO, SCHA.
PNTG has underperformed the market in the last year with a price return of +5.2% while the SPY ETF gained +18.1%. However, in the short term, PNTG had mixed performance relative to the market. It has outperformed in the last 3 months, returning +8.8% vs +2.4% return in SPY. But in the last 2 weeks, PNTG shares have been beat by the market, returning -5.1% compared to an SPY return of +0.4%.
PNTG support price is $27.68 and resistance is $28.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PNTG shares will trade within this expected range on the day.